18 July 2020 - The remdesivir story may actually be good news for the rest of the world. ...
17 July 2020 - NICE has recommended use of Astellas' Xospata (gilteritinib) for adults with relapsed or refractory FLT3 mutation-positive ...
6 July 2020 - Managed entry agreements have been used for several years, with the aim of curbing the growth of ...
14 July 2020 - Collaboration will help NICE expand use of real world data in service of better outcomes for UK ...
13 July 2020 - This paper reports on a retrospective study of individual funding request submissions from a large tertiary hospital ...
10 July 2020 - Single technology assessments published by NICE from April 2011 to October 2018 that evaluated cancer treatments were ...
10 July 2020 - The central task of cost-effectiveness analysis is to identify strategies that maximise health within finite budgets. ...
10 July 2020 - The incremental cost-effectiveness ratio (ICER) is the most commonly reported summary measure for economic evaluations of health ...
10 July 2020 - Takeda's Adcetris (brentuximab vedotin) has won the backing of the National Institute for Health and Care ...
9 July 2020 - Research and knowledge sharing key to collaborative working approach agreed the two agencies. ...
3 July 2020 - Health Technology Assessment International has announced the theme for the 2021 Annual Meeting which will be held ...
5 July 2020 - Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for ...
3 July 2020 - Economic models play a central role in the decision-making process of NICE. ...
30 June 2020 - Cystic fibrosis patients in England will be among the first in Europe to benefit from access to ...
1 July 2020 - NICE has released final guidance on the use of atezolizumab by patients with small cell lung ...